| Vol. 15.01 – 16 January, 2024 |
| |
|
|
| Performed rare variant association studies in a large population cohort to identify inherited predisposition genes for these blood cancers. [Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists combined persistent labeling with time-series single-cell RNA sequencing to build a real-time, quantitative model of in vivo tissue dynamics for murine bone marrow hematopoiesis. [Cell Stem Cell] |
|
|
|
| Investigators performed genome-wide CRISPR/Cas9 screening in the HOXA9-driven reporter acute leukemia cells. They identified a poorly characterized RNA-binding protein, RBM5, as the top candidate gene required to maintain leukemia cell fitness. [Genome Biology] |
|
|
|
| Scientists performed exome sequencing on DNA isolated from newborn bloodspots derived from sibling pairs with early-onset cancers across California in which at least one of the siblings developed a hematologic cancer, using unbiased recruitment from the full state population. [Haematologica] |
|
|
|
| Researchers utilized biotin-labeling of red blood cells (RBCs) to determine the lifespan of RBCs in patients with sickle cell disease compared to patients who have successfully undergone curative hematopoietic stem cell transplantation, participants with sickle cell trait, and healthy donors. [Blood Advances] |
|
|
|
| Flow cytometry analysis showed increased pro-inflammatory monocyte subsets and a decreased classically activated MΦs/alternatively activated MΦs ratio in the bone marrow of patients with higher-risk Myelodysplastic syndromes (MDS) compared to lower-risk MDS. [Journal Of Cellular Physiology] |
|
|
|
| The authors describe the hematopoietic response to infection of mice with Schistosoma mansoni, a parasitic flatworm that causes schistosomiasis. [Journal Of Immunology] |
|
|
|
| A total of 1344 adult patients received an unmanipulated haploidentical transplant at 37 centers from 2012 to 2019 for hematologic malignancy. [Journal Of Hematology & Oncology] |
|
|
|
| This retrospective cohort study compared safety and efficacy of fludarabine, cytarabine, and idarubicin without or with venetoclax in patients with relapsed and refractory acute myeloid leukemia patients. [Haematologica] |
| |
|
|
| The authors analyzed outcomes of 378 patients undergoing first llogeneic haematopoietic cell transplantation between 2006–2017 for t-MN arising secondary to lymphoma treatment. [Bone Marrow Transplantation] |
|
|
|
| Researchers investigated laboratory parameters following hematopoietic stem cell transplantation that can predict the occurrence of sinusoidal obstruction syndrome. [Journal Of Cancer Research And Clinical Oncology] |
| |
|
|
|
| With an emphasis on the invasive characteristics of PM2.5, the authors examine the current knowledge of the health effects of PM2.5 exposure on bone marrowresiding stem cells. [Experimental & Molecular Medicine] |
|
|
|
|
| GenFleet Therapeutics announced that the FDA has granted another two designations for SLS009 (GFH009). GFH009 so far has received both Fast Track Designation and Orphan Drug Designation for the treatment of adult patients with relapsed/refractory peripheral T cell lymphomas and r/r acute myeloid leukemia. [GenFleet Therapeutics] |
|
|
|
|
| March 11 – 13, 2024 Lisbon, Portugal |
|
|
|
|
|
| City of Hope – Duarte, California, United States |
|
|
|
| MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| City of Hope – Duarte, California, United States |
|
|
|
| MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| Albert-Ludwigs-University Freiburg – Freiburg im Breisgau, Germany |
|
|
|
|